Dr. van ‘t Veer is a superwoman in the world of personalized medicine.
For over three decades, she has been advancing breast cancer care through world-shaking innovations, earning her over 230 publications and awards. Renown journal, 24/7 Wall Street named her one of the 32 Amazing Women Inventors who have succeeded in fields dominated by men.
Inspired from a young age, her work is based on the belief that there’s no one-size-fits-all treatment for breast cancer patients. She has made it her mission to increase every woman’s chance of surviving this disease by helping doctors take a more individualized approach to medicine.
Dr. van ‘t Veer is best known for a discovery that she and her team made at the Netherlands Cancer Institute (NKI). They established that a specific DNA signature made up of 70 genes could determine whether breast cancer tumors had a low or high risk of recurrence. This was the foundation for her revolutionary test, MammaPrint. After patenting the innovation, Dr. van ‘t Veer and her research partner, René Bernards, started Agendia as a way to bring MammaPrint and other life-changing genomic technology to breast cancer patients around the world.